NCI-H292/iRFP stable cell line

NCI-H292/iRFP cells are derived from the human NCI-H292 lung carcinoma cell line by stably integration of a constitutive miRFP670 stably expression construct. NCI-H292 cell line has been used for investigating cellular responses to different treatments, studying the mechanisms of cancer progression, and testing potential therapeutic agents. NCI-H292/iRFP cells stably stably express miRFP670, can be used for in vitro assays and in vivo imaging.